# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Advances TriSalus' Platform Focused on Improving Outcomes for Patients with Liver and Pancreatic Cancer Expected to Advanc...
TriSalus Life Sciences®, Inc. (“TriSalus” or the “company”), an oncology company in the process of going public through a busin...
Oncology Therapeutics Company Focused on Transforming Cancer Treatment with Proprietary Innovative Therapies and Disruptive Del...
Merger activity declined last week with three new deals announced and five deals completed. Two of the three new deals announce...